1569 related articles for article (PubMed ID: 23796861)
21. Vigabatrin for infantile spasms.
Pesaturo KA; Spooner LM; Belliveau P
Pharmacotherapy; 2011 Mar; 31(3):298-311. PubMed ID: 21361740
[TBL] [Abstract][Full Text] [Related]
22. Epilepsy in young Tsc1(+/-) mice exhibits age-dependent expression that mimics that of human tuberous sclerosis complex.
Gataullina S; Lemaire E; Wendling F; Kaminska A; Watrin F; Riquet A; Ville D; Moutard ML; de Saint Martin A; Napuri S; Pedespan JM; Eisermann M; Bahi-Buisson N; Nabbout R; Chiron C; Dulac O; Huberfeld G
Epilepsia; 2016 Apr; 57(4):648-59. PubMed ID: 26873267
[TBL] [Abstract][Full Text] [Related]
23. [Treatment of West syndrome].
Cvitanović-Sojat L; Gjergja R; Sabol Z; Hajnzić TF; Sojat T
Acta Med Croatica; 2005; 59(1):19-29. PubMed ID: 15813352
[TBL] [Abstract][Full Text] [Related]
24. High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex.
Hussain SA; Schmid E; Peters JM; Goyal M; Bebin EM; Northrup H; Sahin M; Krueger DA; Wu JY;
Epilepsy Res; 2018 Dec; 148():1-7. PubMed ID: 30296632
[TBL] [Abstract][Full Text] [Related]
25. Seizure remission and antiepileptic drug discontinuation in children with tuberous sclerosis complex.
Sparagana SP; Delgado MR; Batchelor LL; Roach ES
Arch Neurol; 2003 Sep; 60(9):1286-9. PubMed ID: 12975296
[TBL] [Abstract][Full Text] [Related]
26. Vigabatrin for tuberous sclerosis complex.
Curatolo P; Verdecchia M; Bombardieri R
Brain Dev; 2001 Nov; 23(7):649-53. PubMed ID: 11701271
[TBL] [Abstract][Full Text] [Related]
27. Vigabatrin as First-Line Treatment for Infantile Spasms Not Related to Tuberous Sclerosis Complex.
Jones K; Go C; Boyd J; Ochi A; McCoy B; Puka K; Snead OC
Pediatr Neurol; 2015 Aug; 53(2):141-5. PubMed ID: 26227562
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of vigabatrin in the treatment of infantile epileptic spasms syndrome: A systematic review and meta-analysis.
Xu Z; Gong P; Jiao X; Niu Y; Wu Y; Zhang Y; Chang X; Yang Z
Epilepsia Open; 2023 Jun; 8(2):268-277. PubMed ID: 36740237
[TBL] [Abstract][Full Text] [Related]
29. Managing epilepsy in tuberous sclerosis complex.
Thiele EA
J Child Neurol; 2004 Sep; 19(9):680-6. PubMed ID: 15563014
[TBL] [Abstract][Full Text] [Related]
30. Mental retardation and relation to seizure and tuber burden in tuberous sclerosis complex.
Zaroff CM; Barr WB; Carlson C; LaJoie J; Madhavan D; Miles DK; Nass R; Devinsky O
Seizure; 2006 Oct; 15(7):558-62. PubMed ID: 16935530
[TBL] [Abstract][Full Text] [Related]
31. Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Sabril IS Investigator and Peer Review Groups.
Aicardi J; Mumford JP; Dumas C; Wood S
Epilepsia; 1996 Jul; 37(7):638-42. PubMed ID: 8681895
[TBL] [Abstract][Full Text] [Related]
32. Vigabatrin and mental retardation in tuberous sclerosis: infantile spasms versus focal seizures.
Yum MS; Lee EH; Ko TS
J Child Neurol; 2013 Mar; 28(3):308-13. PubMed ID: 22752486
[TBL] [Abstract][Full Text] [Related]
33. Ictal signs in tuberous sclerosis complex: Clinical and video-EEG features in a large series of recorded seizures.
Savini MN; Mingarelli A; Vignoli A; La Briola F; Chiesa V; Peron A; Mai R; Tassi L; Mastrangelo M; Zambrelli E; Turner K; Canevini MP
Epilepsy Behav; 2018 Aug; 85():14-20. PubMed ID: 29906696
[TBL] [Abstract][Full Text] [Related]
34. Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations.
Jansen FE; Braams O; Vincken KL; Algra A; Anbeek P; Jennekens-Schinkel A; Halley D; Zonnenberg BA; van den Ouweland A; van Huffelen AC; van Nieuwenhuizen O; Nellist M
Neurology; 2008 Mar; 70(12):908-15. PubMed ID: 18032745
[TBL] [Abstract][Full Text] [Related]
35. Historical Patterns of Diagnosis, Treatments, and Outcome of Epilepsy Associated With Tuberous Sclerosis Complex: Results From TOSCA Registry.
Nabbout R; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; Beaure d'Augères G; de Vries PJ; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Lawson JA; Macaya A; Marques R; O'Callaghan F; Qin J; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC; Kingswood JC
Front Neurol; 2021; 12():697467. PubMed ID: 34566842
[No Abstract] [Full Text] [Related]
36. [Follow-up of tuberous sclerosis complex complicated by epilepsy in children].
Wen JL; Liao JX; Chen L; Hu Y; Li B; Huang TS; Lu XG; Wang XJ
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Dec; 11(12):996-8. PubMed ID: 20113608
[TBL] [Abstract][Full Text] [Related]
37. On the surgical treatment of refractory epilepsy in tuberous sclerosis complex.
Baumgartner JE; Wheless JW; Kulkarni S; Northrup H; Au KS; Smith A; Brookshire B
Pediatr Neurosurg; 1997 Dec; 27(6):311-8. PubMed ID: 9655146
[TBL] [Abstract][Full Text] [Related]
38. Everolimus treatment of refractory epilepsy in tuberous sclerosis complex.
Krueger DA; Wilfong AA; Holland-Bouley K; Anderson AE; Agricola K; Tudor C; Mays M; Lopez CM; Kim MO; Franz DN
Ann Neurol; 2013 Nov; 74(5):679-87. PubMed ID: 23798472
[TBL] [Abstract][Full Text] [Related]
39. Early control of seizures improves long-term outcome in children with tuberous sclerosis complex.
Bombardieri R; Pinci M; Moavero R; Cerminara C; Curatolo P
Eur J Paediatr Neurol; 2010 Mar; 14(2):146-9. PubMed ID: 19369101
[TBL] [Abstract][Full Text] [Related]
40. [Study on concordance of ictal and interictal epileptiform activity in patients with tuberous sclerosis complex].
Yang Z; Guo Q; Zhuang J; Liu X; Xiong H; Wu Y; Wang S; Chang X; Zhang Y; Bao X; Jiang Y; Qin J
Zhonghua Er Ke Za Zhi; 2014 Apr; 52(4):292-7. PubMed ID: 24915918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
